article thumbnail

The future of medical cannabis development in Europe

European Pharmaceutical Review

Expert Review of Clinical Pharmacology. Plant cannabinoids: a neglected pharmacological treasure trove. British journal of pharmacology. 2005 Dec;146(7):913-5. An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry. 2023 Mar 4;16(3):257-66.

Medical 98
article thumbnail

Patents: a necessary evil?

European Pharmaceutical Review

FDA highlighted that over three quarters of new patents in the Orange Book between 2005 and 2015 were assigned to existing drugs. Patent Protection of Pharmacologically Active Metabolites: Theoretical and Technological Analysis on the Jurisprudence of Four Regions. Method for detecting genotoxic impurities in tenofovir. 2020-02-24.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

4,6 Traditional Herbal Registration The Traditional Herbal Medicines Directive (Directive 2004/24/EC) is implemented in the UK by the Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005 and came into force on 30 April 2011. 2005 [cited 2024May]. 2012/1916). Available from: [link] Barber S.

Marketing 103
article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

She has extensive experience in the biopharmaceutical industry and previously served as Chief Scientific Officer for Novimmune from 2005.